Health

Source link : https://newshealth.biz/health-news/second-anti-her2-tki-approved-for-nsclc/ Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US market. Medscape Medical News Source link : https://www.medscape.com/viewarticle/second-anti-her2-tki-approved-nsclc-2025a1000wan?src=rss Author : Publish date : 2025-11-19 20:59:00 Copyright for syndicated content belongs to the linked Source. The post Second Anti-HER2 TKI Approved for NSCLC first appeared on News Health. —- Author : […] More

Source link : https://newshealth.biz/health-news/new-fda-approved-option-for-her2-mutated-lung-cancer/ (MedPage Today) — The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC). The approval stipulates use in patients who already have received systemic therapy for NSCLC. At the same… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/118608 Author : Publish date : 2025-11-19 21:19:00 Copyright for syndicated content belongs to the linked Source. The […] More

Source link : https://newshealth.biz/health-news/as-infant-botulism-cases-climb-to-31-recalled-formula-still-on-some-store-shelves/ (MedPage Today) — As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the recalled product on some store shelves. Investigators in at least three states… Source link : https://www.medpagetoday.com/publichealthpolicy/productalert/118609 Author : Publish date : 2025-11-19 21:30:00 Copyright for syndicated content belongs […] […] More

Source link : https://newshealth.biz/health-news/medical-groups-outraged-by-anthem-payment-policy-change/ (MedPage Today) — Several medical groups are pushing back on planned payment policy changes announced by Anthem Blue Cross Blue Shield, arguing that these changes may cause physicians to lose hospital privileges and could hurt patient access… Source link : https://www.medpagetoday.com/practicemanagement/reimbursement/118610 Author : Publish date : 2025-11-19 21:46:00 Copyright for syndicated content belongs to the […] […] More

Source link : https://newshealth.biz/health-news/senators-trade-barbs-over-extending-enhanced-obamacare-subsidies/ (MedPage Today) — After watching members of the Senate Finance Committee on Wednesday discuss whether to reinstate the expanded premium tax credits given to certain enrollees in the Affordable Care Act’s (ACA) health insurance exchange plans… Source link : https://www.medpagetoday.com/publichealthpolicy/healthpolicy/118612 Author : Publish date : 2025-11-19 22:24:00 Copyright for syndicated content belongs to the linked […] […] More

Source link : https://newshealth.biz/health-news/california-sober-trend-gets-a-little-support-from-trial/ (MedPage Today) — Smoking cannabis did not cut self-reported alcohol cravings in people with heavy cannabis and alcohol use, but it may reduce the short-term urge to drink and consumption, findings of a randomized trial suggested. Overall, neither… Source link : https://www.medpagetoday.com/psychiatry/addictions/118613 Author : Publish date : 2025-11-19 22:27:00 Copyright for syndicated content belongs to […] […] More

Source link : https://newshealth.biz/health-news/dementia-risk-intertwined-with-exercise-at-two-life-stages/ (MedPage Today) — Physical activity in both midlife and late-life was linked to substantially less dementia risk, a long-term analysis of a large cohort showed. Compared with the lowest quintile of midlife physical activity, the top two quintiles… Source link : https://www.medpagetoday.com/neurology/dementia/118611 Author : Publish date : 2025-11-19 21:50:00 Copyright for syndicated content belongs to […] […] More

Source link : https://newshealth.biz/health-news/mrna-flu-vaccine-tops-standard-shot-in-trial/ (MedPage Today) — A quadrivalent modified mRNA influenza vaccine was more efficacious than a standard quadrivalent inactivated flu vaccine, a randomized phase III trial showed. During the 2022-2023 flu season among people ages 18 to 64, the relative… Source link : https://www.medpagetoday.com/infectiousdisease/uritheflu/118607 Author : Publish date : 2025-11-19 22:00:00 Copyright for syndicated content belongs to […] […] More

Source link : https://newshealth.biz/health-news/bringing-cognitive-assessment-to-the-front-lines-of-primary-care/ (MedPage Today) — More than 7 million Americans live with Alzheimer’s disease, the most common form of dementia. That number is expected to double by 2060. Most people remain undiagnosed until later stages of the disease, with only 8% of those… Source link : https://www.medpagetoday.com/opinion/second-opinions/118602 Author : Publish date : 2025-11-19 19:16:00 Copyright for syndicated […] […] More

Source link : https://newshealth.biz/health-news/better-survival-in-kidney-cancer-after-stopping-therapy-for-immune-related-aes/ (MedPage Today) — DENVER — Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had a trend toward better survival and longer time to treatment failure, according to long-term follow… Source link : https://www.medpagetoday.com/meetingcoverage/ikcs/118606 Author : Publish date : 2025-11-19 20:31:00 Copyright for syndicated content belongs to the linked Source. The […] More

Source link : https://newshealth.biz/health-news/triglyceride-lowering-drug-gets-fda-nod-for-rare-genetic-disorder/ (MedPage Today) — The FDA approved plozasiran (Redemplo) for the reduction of triglycerides in people with familial chylomicronemia syndrome (FCS), the agency announced. The small interfering RNA (siRNA) therapy, designed to reduce triglyceride… Source link : https://www.medpagetoday.com/cardiology/generalcardiology/118604 Author : Publish date : 2025-11-19 19:33:00 Copyright for syndicated content belongs to the linked Source. The post Triglyceride-Lowering […] More

Source link : https://newshealth.biz/health-news/checkpoint-inhibitor-prices-dropped-marginally-over-decade/ A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade. Medscape Medical News Source link : https://www.medscape.com/viewarticle/checkpoint-inhibitor-prices-dropped-marginally-over-decade-2025a1000wa8?src=rss Author : Publish date : 2025-11-19 19:34:00 Copyright for syndicated content belongs to the linked Source. The post Checkpoint Inhibitor Prices Dropped Marginally Over Decade first appeared on News Health. —- […] More